SL
Soleno Ther
SLNO·NASDAQRedwood City CAFounded 201660 employees
Small CapbiotechPublicRare Disease
Platform: DCCR Prader-Willi
Market Cap
$1.5B
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SLNO)
Loading SLNO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Adagrafutibatinib | SLN-4788 | Phase 3 | 4 | PCSK9 | IPFCrohn's | ||
| Fixafutibatinib | SLN-6184 | Phase 1 | 1 | Cl18.2 | T2DRCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)